author-photo

Jian-Li Zhao

Memorial Hospital of South Bend

2

Papers

1

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Metastatic Breast Cancer with Hormone Receptor-positive and HER2-positive (SYSUCC-002).

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)